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Recommendations
There is no evidence that conflicts with the previ-
ous recommendations regarding bone growth stimulation 
published in the original version of the “Guidelines for 
the performance of fusion procedures for degenerative 
disease of the lumbar spine.”18
Grade C
The routine use of DCS in patients over the age of 60 
years is not recommended, as the evidence demonstrates 
no impact on fusion rates (single Level II study).
For patients younger than 60 years of age, undergoing 
a lumbar fusion, the use of DCS is an option as studies 
have demonstrated a positive impact on fusion rate; how-
ever, there is insufficient evidence regarding its impact on 
clinical outcome (single Level III study/multiple Level IV 
studies).
Grade I
There is insufficient evidence to recommend for or 
against the use of PEMFS as a treatment alternative to re-
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The relationship between the formation of a solid arthrodesis and electrical and electromagnetic energy is well 
established; most of the information on the topic, however, pertains to the healing of long bone fractures. The use 
of both invasive and noninvasive means to supply this energy and supplement spinal fusions has been investigated. 
Three forms of electrical stimulation are routinely used: direct current stimulation (DCS), pulsed electromagnetic 
field stimulation (PEMFS), and capacitive coupled electrical stimulation (CCES). Only DCS requires the placement 
of electrodes within the fusion substrate and is inserted at the time of surgery. Since publication of the original guide-
lines, few studies have investigated the use of bone growth stimulators. Based on the current review, no conflict with 
the previous recommendations was generated. The use of DCS is recommended as an option for patients younger 
than 60 years of age, since a positive effect on fusion has been observed. The same, however, cannot be stated for 
patients over 60, because DCS did not appear to have an impact on fusion rates in this population. No study was 
reviewed that investigated the use of CCES or the routine use of PEMFS. A single low-level study demonstrated a 
positive impact of PEMFS on patients undergoing revision surgery for pseudarthrosis, but this single study is insuf-
ficient to recommend for or against the use of PEMFS in this patient population.
(http://thejns.org/doi/abs/10.3171/2014.4.SPINE14326)
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Abbreviations used in this paper: BMP = bone morphogenetic 
protein; CCES = capacitive coupled electrical stimulation; DCS = 
direct current stimulation; DEXA = dual energy x-ray absorptiom-
etry; DPQ = Dallas Pain Questionnaire; LBPRS = Low Back Pain 
Rating Scale; PEMFS = pulsed electromagnetic field stimulation; 
SF-36 = 36-Item Short Form Health Survey; VAS = visual analog 
scale.
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vision surgery in patients presenting with pseudarthrosis 
following posterior lumbar fusion (single Level IV study).
Rationale
Since the publication of the original “Guidelines for 
the performance of fusion procedures for degenerative 
disease of the lumbar spine,”16 the evidence supporting 
the role of lumbar fusion as an effective treatment al-
ternative for a variety of degenerative spinal conditions 
continues to expand.6,9,12,22 As the role of lumbar fusion 
becomes more established, increasing emphasis has been 
placed on maneuvers to enhance the potential for a solid 
arthrodesis. The positive impact of spinal instrumenta-
tion on fusion rates is well recognized.5,11,17 There is also 
a growing body of evidence demonstrating a beneficial 
effect on fusion rates with osteoinductive agents.1,7,8 The 
data supporting the role of bone growth stimulators re-
main inconclusive and more controversial.15,18
The interaction between electrical energy and the for-
mation of an osseous union is a well-recognized concept, 
with the majority of clinical data focusing on long bone 
healing.15 Dwyer published one of the first manuscripts 
describing the utilization of direct current stimulation 
(DCS) for spinal fusion.10 Since this report, 3 forms of 
electrical stimulation have gained acceptance for use in 
spinal fusion: DCS, pulsed electromagnetic field stimula-
tion (PEMFS), and capacitive coupled electrical stimu-
lation (CCES). DCS requires the insertion of cathodes, 
attached to an implanted battery, directly into the fusion 
substrate. PEMFS is a noninvasive means of delivering 
electromagnetic energy to the fusion by wearing an ex-
ternal coil driven by an electrical current. CCES relies 
on the generation of an electrical field through capaci-
tive plates placed on the patient’s skin.15 The purpose of 
this update was to review the current literature and ex-
amine the evidence supporting the clinical utility of vari-
ous bone growth stimulators for lumbar fusion surgery, 
although no studies investigating the efficacy of CCES 
were identified.
Search Criteria
A computerized search of the National Library 
of Medicine MEDLINE database, utilizing the online 
search engine PubMed, was conducted for the period 
from 2003 through December 2011 utilizing the fol-
lowing search terms (((“Lumbosacral Region”[MeSH] 
OR “Lum bar Vertebrae”[MeSH]) AND “Spinal Fusion” 
[MeSH]) OR “lumbar fusion”[All Fields] OR (“lum bar” 
[title] AND “fusion”[title])) AND ((bone growth stim-
u la tor[title] OR bone growth stimulators[title]) OR 
(“Electric Stimulation”[MeSH] OR “Electric Stimula-
tion Ther apy”[MeSH] OR ((“bone and bones”[MeSH] 
OR (“bone”[All Fields] AND “bones”[All Fields]) OR 
“bone and bones”[All Fields] OR “bone”[All Fields]) AND 
stimulator[All Fields]) OR ((“bone and bones”[MeSH] 
OR (“bone”[All Fields] AND “bones”[All Fields]) OR 
“bone and bones”[All Fields] OR “bone”[All Fields]) AND 
stimulators[All Fields]))). The search was limited to the 
English language and human subjects and yielded a total 
of 44 articles. The titles and abstracts of these publications 
were reviewed and those specifically investigating the 
clinical efficacy of bone growth stimulation were selected. 
A secondary review of the bibliographies of these articles 
was conducted to identify any additional relevant manu-
scripts. A total of 5 manuscripts were selected and serve as 
the scientific foundation for the updated review.
Scientific Foundation
Andersen et al. performed a randomized, controlled, 
multicenter trial to determine the impact of DCS on func-
tional outcome of noninstrumented lumbar fusion for pa-
tients over 60 years of age.3 One hundred seven patients 
presenting with a variety of spinal degenerative disorders 
and undergoing single or multilevel posterolateral lumbar 
fusion (PLF) with local autograft and allograft were ran-
domized into cohorts with a 40-mA (n = 44) or 100-mA (n 
= 11) DCS implanted stimulator or without (n = 43) DCS. 
For a variety of reasons, 9 randomized patients were ex-
cluded either prior to surgery or due to intraoperative com-
plications. Patients completed a series of validated, objec-
tive outcome instruments (the 36-Item Short Form Health 
Survey [SF-36], the Dallas Pain Questionnaire [DPQ], and 
the Low Back Pain Rating Scale [LBPRS]), and statisti-
cal analysis was performed to compare treatment effect. 
Patients were followed up for 2 years; however, 27% of 
patients did not complete the functional outcome question-
naires at this end point. At the 2-year point, the patients in 
the combined treatment group demonstrated significantly 
greater improvement in 3 of the 4 domains of the DPQ, al-
though no significant difference in LBPRS or SF-36 scores 
was observed. Based on these results the authors concluded 
that surgery led to an improvement in functional outcome 
and that DCS may have a beneficial effect on lumbar fu-
sion in older patients. This is a relatively well-designed 
randomized trial, but the study does suffer from several 
limitations. The validity of separating the results of the in-
dividual domains within the DPQ is unclear because the 
overall percentages are graphed to create a profile sum-
mary of the patient.14 Variability existed with respect to 
the presenting diagnosis and surgical intervention. It is not 
clear who performed the functional assessment and wheth-
er that individual was blinded to the treatment received. 
At the 2-year follow-up, only 73% of the participants com-
pleted the functional assessment questionnaires. Finally, 
the statistical analysis was limited by the authors’ failure 
to determine the confidence intervals for the observed re-
sults. Due to these limitations the study was downgraded 
to Level II evidence supporting the role of DCS for this 
patient population undergoing noninstrumented lumbar fu-
sion (Table 1).
Anderson and colleagues published 2 additional 
studies based on the same patient population with the in-
tention of determining the effect of DCS on fusion rate, 
correlating the radiographic outcome to clinical outcome, 
and clarifying whether DCS had an impact on the qual-
ity of fusion.2,4 Of the original 107 patients randomized, 
95 were available for fusion assessment at 1 year and 84 
were available at 2 years. Thin-slice CT images and plain 
radiographs were used to assess fusion status. In both the 
control and treatment cohorts the observed fusion rate was 
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low—33% and 32%, respectively. The authors concluded 
that the utilization of DCS had no impact on fusion rate. 
There was a poor correlation between the observations 
made from CT images and plain radiographs, although 
a solid fusion, as defined by CT, resulted in better func-
tional outcome and less pain2 (Table 1). The final study 
from this series demonstrated, through the use of dual en-
ergy x-ray absorptiometry (DEXA), that the application 
of DCS had no impact on the bone mineral density of the 
fusion mass.4 These investigations suffer from the same 
limitations as the first study in this series. The blinded 
radiographic assessment of the CT imaging strengthens 
the observations and conclusions regarding the impact of 
DCS on fusion rate. Although the authors claim that there 
was an 89% follow-up rate at 2 years, this was calculated 
from the 95 patients undergoing imaging at 1 year and not 
from the original 107 patients randomized at the onset of 
the study. Like the original study, this investigation was 
downgraded and provides Level II evidence against the 
utility of DCS to enhance the fusion rate for noninstru-
mented lumbar fusion. In a follow-up study, Andersen et 
al. investigated the impact of DCS on the quality of fu-
sion formation by examining 80 of the original 107 pa-
tients with DEXA at 1 year after surgery. No significant 
difference in bone mineral density was observed between 
the 3 treatment groups.
Rogozinski et al. conducted a prospective, nonran-
domized trial comparing radiographic outcome in 31 pa-
tients with the diagnosis of degenerative disc disease, who 
underwent 1- to 3-level instrumented PLF supplemented 
with either bone morphogenetic protein (BMP) or an im-
planted DC stimulator.20 Fusion status was assessed using 
plain radiographs and/or CT, and pain status was deter-
mined through a 10-point visual analog scale (VAS). The 
BMP cohort demonstrated a 100% fusion rate, while the 
stimulator group demonstrated a 93.4% fusion rate. The 
BMP cohort was considered to achieve more robust fusion 
at a faster rate than the stimulator cohort. Pain improved in 
both cohorts. The authors concluded that the use of BMP 
led to more rapid graft maturation and a more robust fu-
sion compared with fusions supplemented with an internal 
stimulator. The actual treatment effect of DCS compared 
with traditional fusion techniques cannot be determined 
from this study because all patients received some form of 
fusion supplement, but the fusion rate observed in the DCS 
cohort is comparable to previously reported rates of fusion 
for similar patients without DCS. This investigation also 
suffers from major limitations with respect to study design, 
including a small, heterogeneous patient cohort, lack of in-
clusion and exclusion criteria, and heterogeneous surgical 
treatments. Only 9 patients were available for CT imaging 
at 2 years after surgery (79% lost to follow-up), the assess-
ment of the images was performed by the treating surgeon, 
and the criteria for fusion were not defined. This study was 
therefore downgraded to Level III evidence, although one 
may consider it simply a case series with respect to the 
DCS data (Table 1).
Two additional studies have also demonstrated a 
positive impact of DCS on fusion formation. Kucharzyk 
performed a retrospective review of 130 cases involving 
patients undergoing lumbar fusion with (n = 65) and with-
out (n = 65) placement of DCS.13 Fusion status was deter-
mined through both CT images and plain radiographs. 
The average follow-up was 3.8 years. The fusion rate in 
the DCS cohort was 95.6%, while the rate in the control 
group was 87%. Clinical success, utilizing a nonvali-
dated outcome measure, was superior in the DCS group. 
Rogozinski and Rogozinski also performed a retrospec-
tive review of 94 cases, with 53 of the patients receiving 
a DCS, and observed a fusion rate of 96% in the DCS 
cohort and 85% in the control arm.19 Both of these studies 
suffer from a heterogeneous population of patients, lim-
ited baseline demographic data, and either failure to re-
port clinical outcome or use of a nonvalidated instrument. 
Due to these limitations these studies are downgraded to 
Level IV evidence in support of the use of DCS with lum-
bar fusions.
Simmons et al. published a case series involving 100 
patients with a mean age of 43.3 years who presented 
with pseudarthrosis after an attempt at single- or multi-
level lumbar fusions and were treated with pulsed elec-
tromagnetic field stimulation (PEMFS).21 Pseudarthrosis 
was confirmed by the presence of motion on dynamic im-
aging and the lack of visible bone healing on CT, MRI, or 
radiographic images. Twenty-five investigators from mul-
tiple institutions enrolled the 100 patients, who received 
PEMFS for at least 90 days. The investigators as well as 
a blinded radiologist performed radiographic evaluation 
of fusion. If there was disagreement among reviewers, an 
independent evaluation was performed by a blinded or-
thopedist. A solid fusion was defined as 50% or more as-
similation of the graft based on radiographic imaging; the 
specific imaging technique was not defined. Clinical out-
come was rated as excellent, good, fair, or poor, based on 
patients’ reported pain intensity, medication usage, and 
return to work. The fusion success rate was 67%, and 63% 
of the patients with successful fusion demonstrated an ex-
cellent or good outcome. Only 30% of patients with per-
sistent pseudarthrosis had an excellent or good outcome. 
The authors concluded that PEMFS was an effective al-
ternative to revision surgery for patients presenting with 
pseudarthrosis. Although this study provides evidence 
that the utilization of PEMFS is a feasible intervention 
for the management of pseudarthrosis, the true treatment 
effect cannot be determined due to the study design and 
lack of an adequate control group. The authors also fail to 
define the criteria used to diagnose pseudarthrosis and in-
cluded a heterogeneous population of patients. The study 
therefore provides at best Level IV evidence in support of 
PEMFS for treatment of pseudarthrosis (Table 1).
Summary
Based on the recommendations from the original 
guidelines, both DCS and CCES may be considered in 
patients at high risk for pseudarthrosis who are undergo-
ing PLF, while PEMFS may be considered in a similar pa-
tient population undergoing an interbody fusion. Since the 
publication of the previous guidelines, there have been few 
clinical trials that provide further insight into the clinical 
utility of bone growth stimulation. The current data do not 
contribute to the previous recommendations.
M. G. Kaiser et al.
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The few studies that have investigated the use of 
bone growth stimulators have methodological flaws that 
compromise the conclusions and prohibit the formulation 
of strong recommendations. Based on a single Level II 
study, there is a suggestion that the use of DCS in patients 
over 60 years of age may provide a clinical benefit; how-
ever, this benefit was only observed in a subset of mea-
sures from a single outcome instrument and therefore is 
considered a weak correlation. This potential beneficial 
effect is further weakened by the fact that DCS did not 
have a positive impact on the fusion rate or quality in the 
same patient population. The weak correlation to clini-
cal outcome may therefore be an artifact of the flawed 
study design or simply due to chance. Since the intended 
purpose of DCS was not supported by the authors’ obser-
vations, the routine use of DCS in patients over 60 years 
of age undergoing a noninstrumented fusion was not rec-
ommended.
The second recommendation supports the use of 
PEMFS in patients suffering from a pseudarthrosis, but 
no comment can be made regarding the routine use of 
PEMFS. Due to the noninvasive nature of PEMFS, its ap-
plication appears to be relatively benign with few draw-
backs; however, in today’s medical climate one cannot ig-
nore the costs associated with an intervention that has not 
been proven to provide definitive benefit. Unfortunately, 
the quality of the current literature does not help to ad-
dress these concerns.
Key Issues for Future Investigation
The impact of bone growth stimulators on fusion 
rates is likely to be minimal, and this makes it difficult 
to conduct a clinical trial to determine the actual treat-
ment effect and/or compare the efficacy of different types 
of stimulators. Given the noninvasive nature of PEMFS, 
a well-designed randomized controlled trial is feasible. 
Such a study would, however, require an exceedingly 
large number of patients to demonstrate the difference in 
treatment effect. Nevertheless, such information would 
prove valuable, not only from a clinical perspective, but 
also for effective cost analysis, which ultimately may be 
the more relevant issue in today’s medical climate. Utili-
zation of a prospective patient registry may also provide 
relevant information by identifying specific patient popu-
lations that would benefit from any advantage provided 
by fusion enhancers, such as bone growth stimulators.
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